January 26, 2023
REDWOOD CITY, Calif. , Jan. 26, 2023 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage ...
Read MoreDecember 19, 2022
Funding from three leading healthcare investors, with Vivo Capital joining existing investors Nantahala Capital and ...
Read MoreNovember 09, 2022
REDWOOD CITY, Calif. , Nov. 09, 2022 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage ...
Read More
Developing novel therapeutics for the treatment of rare diseases.